Endoskopische retrograde Cholangiopankreatographie Marktanalyse</font></font>

Name: Markt für endoskopische retrograde Cholangiopankreatikographie nach Produkt (Endoskope des oberen Gastrointestinaltrakts, Stents, Ballons, Katheter, Körbe), Verfahren (Gallensphinkterotomie und Stenting, Pankreassphinkterotomie), Endverbraucher (Krankenhäuser) und Region (Nordamerika, Europa, Asien-Pazifik, Naher Osten und Afrika sowie Südamerika), globale Trends und Prognose von 2022 bis 2029
Price: 3499 USD
Availability: InStock
Rating: 4.5 (91 reviews)
Author: Exactitude Consultancy
ISBN: 8948

Marktübersicht

Der globale Markt für endoskopische retrograde Cholangiopankreatikographie wird voraussichtlich von 2022 bis 2029 um durchschnittlich 9,7 % jährlich wachsen. Es wird erwartet, dass er von 1,18 Milliarden US-Dollar im Jahr 2020 auf über 2,73 Milliarden US-Dollar im Jahr 2029 ansteigt.

Endoskopische retrograde Cholangiopankreatikographie (ERCP) Geräte werden zur Diagnose und Behandlung der Gallenwege, der Bauchspeicheldrüse und der Ampulle bei Vater-Krankheiten eingesetzt. Kontrastmittel kann bei dieser Methode direkt in den gemeinsamen Lebergang, den Pankreasgang oder die Arteria cystica injiziert werden.

Da die Häufigkeit von Gallensteinen und Bauchspeicheldrüsenkrebs zunimmt, wird die Nachfrage nach diesen Geräten in naher Zukunft voraussichtlich steigen. Darüber hinaus hat die Einführung minimalinvasiver Operationstechniken die Zahl der Patienten erhöht, die ERCP-Verfahren wünschen, was dem Markt in den nächsten Jahren zum Wachstum verhelfen wird. Cholangiokarzinom (Gallengangskrebs) ist laut der American Cancer Society im Januar 2021 eine seltene Krebserkrankung. In den Vereinigten Staaten werden jedes Jahr etwa 8.000 Menschen damit diagnostiziert. Die Gallengänge sind sowohl intrahepatisch (innerhalb der Leber) als auch extrahepatisch (außerhalb der Leber).

ATTRIBUT	DETAILS
Studiendauer	2020–2029
Basisjahr	2021
Geschätztes Jahr	2022
Voraussichtliches Jahr	2022–2029
Historischer Zeitraum	2018-2020
Einheit	Wert (Milliarden USD)
Segmentierung	Nach Produkt, nach Verfahren, nach Endbenutzer
Nach Produkt	Obere GI-Endoskope Stent Luftballons Katheter Körbe
Nach Verfahren	Gallengangssphinkterotomie und Stenteinlage Pankreassphinkterotomie
Nach Endbenutzer	Krankenhäuser
Nach Region	Nordamerika Europa Asien-Pazifik Südamerika Naher Osten und Afrika

People have become more interested in minimally invasive operations in recent years, rather than typical open surgeries that need large incisions through the muscles. It takes a long time for these muscles to recover. The main benefit of minimally invasive surgeries (MIS) over traditional open surgeries is higher precision due to video-assisted equipment, which produces a better and magnified image of the organs or body parts being operated on, as well as other significant benefits such as less major bleeding, fewer post-op infections, fewer complications, shorter length of stay, faster return to normal activities, less scarring, and comparable/lower cost, among others. As a result, these operations have recently grown more common.

Cancer is becoming more common over the world. According to the World Health Organization, cancer is the second biggest cause of death worldwide, accounting for 10 million deaths in 2020. According to the American Cancer Society, there will be 41,260 new instances of liver cancer and intrahepatic bile duct cancer diagnosed in the United States in 2022. Since 1980, the incidence of liver cancer has more than tripled, while the fatality rate has more than doubled. Around 60,430 new pancreatic cases were detected in the United States in 2021. Every year, around 10,500 new pancreatic cancer cases and 6,200 new liver cancer cases are diagnosed in the United Kingdom (2016-2018). In 2018, 458,918 new cases of pancreatic cancer were recorded worldwide, with 355,317 new cases expected in 2040. Because ERCP is frequently used to diagnose hepatic, bile duct, and pancreatic tumors, the increased prevalence of these malignancies has a direct impact on the ERCP market.

One of the major restraining factors for the market is the high costs of ERCP equipment and procedures. Also factor like long procedure time is obstructing the market growth.

The BRICS countries (Brazil, Russia, India, China, and South Africa) are among the world's fastest-growing economies. In 2021, emerging economies accounted for almost one-third of global healthcare spending, according to the World Economic Forum. Because India and China are home to more than half of the world's population, these countries have the biggest number of patients. The rising cancer burden, quick improvements in healthcare infrastructure, the rapid rise of medical tourism, and the presence of flexible legislation in these nations all encourage endoscopy equipment manufacturers to expand their operations in these countries.

Die COVID-19-Pandemie hat sich negativ auf den Markt ausgewirkt. Eine COVID-19-Infektion betrifft häufiger Chirurgen und Patienten, die für verschiedene Eingriffe häufig ins Krankenhaus kommen. Die Mehrzahl der Magen-Darm-Operationen wurde gestoppt, was zu einem Rückgang gerätebasierter Behandlungen wie ERCP führte. In großen Krankenhäusern in ganz Deutschland wurden etwa 40–50 Prozent der endoskopischen Eingriffe abgesagt. Laut einer Studie führte die COVID-19-Pandemie zu einer erheblichen Reduzierung der ERCP-Eingriffe. Aufgrund weltweiter Einschränkungen bei endoskopischen Dienstleistungen verringerte sich auch die Erfolgsrate. Die Endoskopie wird als aerosolerzeugendes Verfahren eingestuft, bei dem ein Übertragungsrisiko für medizinisches Personal besteht.

[Bildunterschrift id="attachment_8950" align="alignleft" width="870"]

Endoscopic Retrograde Cholangiopancreatography Market | Exactitude Consultancy

Markt für endoskopische retrograde Cholangiopankreatikographie | Exactitude Consultancy[/Untertitel]

Frequently Asked Questions

• What is the worth of global endoscopic retrograde cholangiopancreatography market?

The endoscopic retrograde cholangiopancreatography market size had crossed 1.18 USD Billion in 2020 and will observe a CAGR of more than 9.7% up to 2029 driven by the rising technological advancements in molecular biology, genomics, and microbial diversity.

• What is the size of the North America endoscopic retrograde cholangiopancreatography industry?

North America held more than 25% of the endoscopic retrograde cholangiopancreatography market revenue share in 2020 and will witness expansion with the improved healthcare system.

• What are the upcoming trends of endoscopic retrograde cholangiopancreatography market, globally?

The upcoming trends in endoscopic retrograde cholangiopancreatography market are expansion in F&B industry, along with development in extraction technology.

• What is the CAGR of endoscopic retrograde cholangiopancreatography market?

The global endoscopic retrograde cholangiopancreatography market registered a CAGR of 9.7% from 2022 to 2029. The endotherapy devices segment was the highest revenue contributor to the market.

• Which are the top companies to hold the market share in endoscopic retrograde cholangiopancreatography market?

Key players profiled in the report include Olympus Corporation, CONMED Corporation, Fujifilm Holdings Corporation, HOYA Corporation, KARL STORZ SE & Co. KG, Ambu A/S, Boston Scientific Corporation, Johnson & Johnson, Medtronic, PLC, Cook Medical, and B. Braun Melsungen AG.

• What is the leading application of endoscopic retrograde cholangiopancreatography market?

It is used to diagnose and treat the biliary tract, pancreas, and ampulla of Vater illnesses.

• Which is the largest regional market for endoscopic retrograde cholangiopancreatography market?

Asia-Pacific is the largest regional market for endoscopic retrograde cholangiopancreatography market.

Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis

On the basis of product, the market is segmented into Upper GI endoscopes, Stent, Balloons, Catheters, Baskets. Based on procedures the ERCP market is segmented into Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy.

During the forecast period, the Endo therapy devices segment held the biggest market share by product type. The growing inclination for less invasive operations and the rising prevalence of gastrointestinal diseases are two variables contributing to the Endo therapy devices segment's significant revenue.

Sphincterotomes accounted for the greatest market share in the Endo therapy devices segment throughout the projection period. This can be ascribed to an increase in biliary problems due to the rising incidence of pancreatic duct and bile duct stones, as well as the growing geriatric population.

[caption id="attachment_8951" align="alignleft" width="680"]

Endoscopic Retrograde Cholangiopancreatography Market | Exactitude Consultancy[/caption]

Endoscopic Retrograde Cholangiopancreatography Market Players

The major players in the global endoscopic retrograde cholangiopancreatography market include Olympus Corporation, CONMED Corporation, Fujifilm Holdings Corporation, HOYA Corporation, KARL STORZ SE & Co. KG, Ambu A/S, Boston Scientific Corporation, Johnson & Johnson, Medtronic, PLC, Cook Medical, and B. Braun Melsungen AG.

These companies have adopted various organic as well as inorganic growth strategies to strengthen their position in the market. New product development, merger & acquisition, and expansion were among the key growth strategies adopted by these leading players to enhance their product offering and regional presence and meet the growing demand for endoscopic retrograde cholangiopancreatography in the emerging economies.

Who Should Buy? Or Key stakeholders

Endoscopic retrograde cholangiopancreatography suppliers
Investors
Manufacturing companies
End-user companies
Research institutes
Medical sector
Environment, Health and Safety Professionals

Endoscopic Retrograde Cholangiopancreatography Market Regional Analysis

The global endoscopic retrograde cholangiopancreatography market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).

North America: includes the US, Canada, Mexico
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

During the forecast period, the Asia Pacific and Latin American markets are expected to grow at the fastest rates. The high growth in this regional market can be attributed to Japan's well-developed healthcare system, which includes universal health insurance coverage, and countries like China and India focusing on improving healthcare infrastructure to serve large populations of patients with critical illnesses, such as cancer and tumors. In addition, governments in a number of Latin American countries are working to improve their healthcare systems. Brazil's healthcare sector has seen tremendous transformations, making it one of the world's most promising and appealing sectors.

[caption id="attachment_8953" align="alignleft" width="680"]

Endoscopic Retrograde Cholangiopancreatography Market | Exactitude Consultancy[/caption]

Key Market Segments: Global Endoscopic retrograde cholangiopancreatography Market Global Endoscopic Retrograde Cholangiopancreatography Market by Product, 2020-2029, (USD Million) (Thousand Units)

Upper GI Endoscopes
Stent
Balloons
Catheters
Baskets

Global Endoscopic Retrograde Cholangiopancreatography Market by Procedure, 2020-2029, (USD Million) (Thousand Units)

Biliary Sphincterotomy & Stenting
Pancreatic Sphincterotomy

Global Endoscopic Retrograde Cholangiopancreatography Market by End-User, 2020-2029, (USD Million) (Thousand Units)

Hospitals

Global Endoscopic Retrograde Cholangiopancreatography Market by Region, 2020-2029, (USD Million) (Thousand Units)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries In All Regions Are Covered.

EINFÜHRUNG
1. MARKTDEFINITION
2. MARKTSEGMENTIERUNG
3. FORSCHUNGSZEITPLAN
4. ANNAHMEN UND EINSCHRÄNKUNGEN

FORSCHUNGSMETHODIK
1. DATENMINING
  1. Sekundärforschung
  2. PRIMÄRFORSCHUNG
  3. RAT VON FACHEXPERTEN
2. QUALITÄTSPRÜFUNGEN
  1. ABSCHLIESSENDE ÜBERPRÜFUNG
3. DATENTRIANGULATION
  1. Bottom-Up-Ansatz
  2. TOP-DOWN-ANSATZ
  3. FORSCHUNGSABLAUF
4. DATENQUELLEN

ZUSAMMENFASSUNG

MARKTÜBERSICHT
1. GLOBALER MARKTAUSBLICK FÜR DIE ENDOSKOPISCHE RETROGRADE CHOLANGIOPANKREATOGRAPHIE
  1. MARKTTREIBER
  2. Marktbeschränkungen
  3. Marktchancen
2. Auswirkungen von COVID-19 auf den globalen Markt für endoskopische retrograde Cholangiopankreatografie

GLOBALER MARKT FÜR ENDOSKOPISCHE RETROGRADE CHOLANGIOPANKREATOGRAPHIE NACH PRODUKT (MIO. USD) (TAUSEND EINHEITEN)
1. ENDOSKOPE FÜR DEN OBEREN GI-RAUM
2. STENT
3. Luftballons
4. KATHETER
5. KÖRBE

GLOBALER MARKT FÜR ENDOSKOPISCHE RETROGRADE CHOLANGIOPANKREATOGRAPHIE NACH VERFAHREN (MIO. USD) (TAUSEND EINHEITEN)
1. Gallengangssphinkterotomie und Stenting
2. PANKREAS-SPHINKTEROTOMIE

GLOBALER MARKT FÜR ENDOSKOPISCHE RETROGRADE CHOLANGIOPANKREATOGRAPHIE NACH ENDBENUTZER, (MIO. USD) (TAUSEND EINHEITEN)
1. KRANKENHÄUSER

GLOBALER MARKT FÜR ENDOSKOPISCHE RETROGRADE CHOLANGIOPANKREATOGRAPHIE NACH REGIONEN (MIO. USD) (TAUSEND EINHEITEN)
1. EINFÜHRUNG
2. ASIEN-PAZIFIK
  1. CHINA
  2. INDIEN
  3. JAPAN
  4. SÜDKOREA
  5. AUSTRALIEN
  6. SÜDOSTASIEN
  7. RESTLICHER ASIEN-PAZIFIK-RAUM
3. NORDAMERIKA
  1. VEREINIGTE STAATEN
  2. KANADA
  3. MEXIKO
4. EUROPA
  1. DEUTSCHLAND
  2. VEREINIGTES KÖNIGREICH
  3. FRANKREICH
  4. ITALIEN
  5. SPANIEN
  6. RUSSLAND
  7. RESTLICHES EUROPA
5. SÜDAMERIKA
  1. BRASILIEN
  2. ARGENTINIEN
  3. KOLUMBIEN
  4. RESTLICHES SÜDAMERIKA
6. NAHER OSTEN UND AFRIKA
  1. Vereinigte Arabische Emirate
  2. SAUDI-ARABIEN
  3. SÜDAFRIKA
  4. RESTLICHER NAHER OSTEN UND AFRIKA

FIRMENPROFILE* (GESCHÄFTSÜBERBLICK, FIRMENIMPORT, ANGEBOTENE PRODUKTTYPEN, NEUESTE ENTWICKLUNGEN)
1. OLYMPUS CORPORATION
2. CONMED CORPORATION
3. FUJIFILM HOLDINGS CORPORATION
4. HOYA CORPORATION
5. KARL STORZ SE & CO. KG
6. AMBU A/S
7. BOSTON SCIENTIFIC CORPORATION
8. JOHNSON & JOHNSON
9. MEDTRONIC, PLC
10. KOCH MEDIZIN
11. BRAUN MELSUNGEN AG *DIE FIRMENLISTE IST INDIKATIVER NATUR

TABELLENLISTE

TABLE 1                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 2                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 3                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 4                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029
TABLE 5                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 6                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 7                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY REGION (USD MILLIONS), 2020-2029

TABLE 8                GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY REGION (THOUSAND UNITS), 2020-2029

TABLE 9                NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 10              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 11              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 12              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 13              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 14              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 15              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 16              NORTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 17              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 18              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 19              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 20              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 21              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 22              US ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 23              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (MILLIONS), 2020-2029

TABLE 24              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 25              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 26              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 27              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 28              CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 29              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 30              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 31              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 32              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 33              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 34              MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 35              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 36              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 37              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 38              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 39              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 40              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 41              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 42              SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 43              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 44              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 45              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 46              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 47              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 48              BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 49              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 50              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 51              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 52              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 53              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 54              ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 55              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 56              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 57              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 58              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 59              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 60              COLOMBIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 61              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 62              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 63              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 64              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 65              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 66              REST OF SOUTH AMERICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 67              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 68              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 69              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 70              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 71              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 72              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 73              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 74              ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 75              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 76              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 77              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 78              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 79              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 80              INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 81              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 82              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 83              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 84              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 85              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 86              CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 87              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 88              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 89              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 90              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 91              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 92              JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 93              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 94              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 95              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 96              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 97              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 98              SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 99              AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 100            AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 101            AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 102            AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 103            AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 104            AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 105            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 106            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 107            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 108            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 109            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 110            SOUTH EAST ASIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 111            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 112            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 113            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 114            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 115            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 116            REST OF ASIA PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 117            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 118            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 119            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 120            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 121            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 122            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 123            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 124            EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 125            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 126            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 127            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 128            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 129            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 130            GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 131            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 132            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 133            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 134            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 135            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 136            UK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 137            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 138            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 139            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 140            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 141            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 142            FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 143            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 144            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 145            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 146            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 147            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 148            ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 149            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 150            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 151            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 152            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 153            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 154            SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 155            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 156            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 157            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 158            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 159            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 160            RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 161            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 162            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 163            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 164            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 165            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 166            REST OF EUROPE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 167            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (USD MILLIONS), 2020-2029

TABLE 168            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029

TABLE 169            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 170            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 171            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 172            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 173            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 174            MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 175            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 176            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 177            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 178            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 179            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 180            UAE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 181            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 182            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 183            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 184            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 185            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 186            SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 187            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 188            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 189            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 190            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 191            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 192            SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

TABLE 193            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (USD MILLIONS), 2020-2029

TABLE 194            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029

TABLE 195            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (USD MILLIONS), 2020-2029

TABLE 196            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE (THOUSAND UNITS), 2020-2029

TABLE 197            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (USD MILLIONS), 2020-2029

TABLE 198            REST OF MIDDLE EAST AND AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER (THOUSAND UNITS), 2020-2029

LIST OF FIGURES

FIGURE 1             MARKET DYNAMICS

FIGURE 2             MARKET SEGMENTATION

FIGURE 3             REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4             DATA TRIANGULATION

FIGURE 5             BOTTOM-UP APPROACH

FIGURE 6             TOP-DOWN APPROACH

FIGURE 7             RESEARCH FLOW

FIGURE 8             GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, USD MILLION, 2020-2029

FIGURE 9             GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, USD MILLION, 2020-2029

FIGURE 10           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER, USD MILLION, 2020-2029

FIGURE 11           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 12           PORTER’S FIVE FORCES MODEL

FIGURE 13           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PRODUCT, USD MILLION, 2020-2029

FIGURE 14           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY PROCEDURE, USD MILLION, 2020-2029

FIGURE 15           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY END-USER, USD MILLION, 2020-2029

FIGURE 16           GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 17           ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET BY REGION 2021

FIGURE 18           MARKET SHARE ANALYSIS

FIGURE 19           OLYMPUS CORPORATION: COMPANY SNAPSHOT

FIGURE 20           CONMED CORPORATION: COMPANY SNAPSHOT

FIGURE 21           FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT

FIGURE 22           HOYA CORPORATION: COMPANY SNAPSHOT

FIGURE 23           KARL STORZ SE & CO. KG: COMPANY SNAPSHOT

FIGURE 24           AMBU A/S: COMPANY SNAPSHOT

FIGURE 25           BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

FIGURE 26           JOHNSON & JOHNSON, MEDTRONIC PLC: COMPANY SNAPSHOT

FIGURE 27           COOK MEDICAL: COMPANY SNAPSHOT

FIGURE 28           B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

Identifying Key Products in the Market

The identification of key products in any market is pivotal for understanding what drives consumer interest, technological innovation, and competitive advantage. Here’s how to approach this:
Market Analysis Reports: Start with syndicated market analysis reports from firms like Nielsen, Euromonitor, or specialized industry analysts. These reports often highlight leading products based on sales data, innovation, and consumer feedback.
Patent Filings: Reviewing patent filings can provide insight into technological innovations and future products that may impact the market. Databases like the United States Patent and Trademark Office (USPTO) or the World Intellectual Property Organization (WIPO) can be invaluable.
Ecommerce Platforms and Retailer Websites: Analyzing bestselling products and customer reviews on platforms such as Amazon, Flipkart, or direct retailer websites can offer direct insights into consumer preferences and product popularity.
Consumer Surveys and Feedback: Conducting surveys or analyzing online forums and social media can reveal consumer preferences, pain points, and desired features in products. Tools like SurveyMonkey, Google Surveys, or social listening platforms can facilitate this process.

Segmenting the Market and Products

Market and product segmentation is crucial for targeting marketing efforts and product development. Here’s a methodology for segmenting based on technical specifications:
Technical Specifications Review: Compile a comprehensive list of products within the market, focusing on their technical specifications. This could involve processor speeds for electronics, ingredients for food products, or material composition for apparel.
Factor Analysis: Use statistical techniques like factor analysis to group products based on shared technical specifications. This method helps identify underlying relationships between different specifications and how they cluster together.
Expert Consultation: Engage with industry experts or technical specialists to ensure that the segmentation makes sense from both a market and a technical perspective. This step ensures the practical relevance of the segments identified.

Identifying and Classifying Key Application Segments

Understanding how products are used in different applications is essential for market strategy:
Use Case Analysis: Identify common use cases for products by reviewing product literature, customer testimonials, and case studies. This helps understand the variety of applications each product serves.
Industry Surveys: Conduct surveys targeting professionals in the field to understand how and why certain products are preferred in specific applications. This can also reveal unmet needs in the market.
ApplicationBased Segmentation: Group products based on their primary applications, considering factors such as industry use, consumer vs. professional use, and environmental conditions.

Calculating Market Size Using TopDown and BottomUp Approaches

Estimating the market size accurately is fundamental for strategic planning:
TopDown Approach: Start with global industry data and narrow down to the target market by applying known market shares or segmentation percentages. Industry reports and financial databases are key sources for this approach.
BottomUp Approach: Aggregate sales data or unit shipments from all known market participants. This might require gathering data from company reports, industry associations, and sales channels.
Combining Approaches: Validate the market size estimates by comparing the results from both approaches. Discrepancies can highlight areas requiring further investigation.

Calculating the CAGR for the Market

The Compound Annual Growth Rate (CAGR) is a useful measure to understand market growth over time:
Historical Sales Data: Gather historical sales or market size data over a defined period. Public company filings, industry reports, and government databases can be sources for this data.
CAGR Formula: Apply the CAGR formula \[CAGR = (EV/BV)^{1/n} 1\], where EV is the end value, BV is the beginning value, and n is the number of periods.
Segment and Overall Market CAGR: Calculate CAGR for both the overall market and individual segments to understand growth patterns.

Sources for Secondary or Desk Research

Identifying the right sources is crucial for accurate desk research:
Industry and Market Research Reports: Sources like IBISWorld, Statista, and Frost & Sullivan offer comprehensive industry reports.
Government and International Organizations: Websites of the U.S. Census Bureau, World Bank, and OECD provide economic and industry specific data.
Academic Journals: Platforms like Google Scholar and JSTOR can offer peer reviewed articles on market trends and consumer behavior.
News Archives and Trade Publications: Stay informed on industry developments through sources like Bloomberg, Reuters, and specific trade journals relevant to the market in question.
Each of these steps requires careful consideration and a systematic approach to ensure that the market research report is robust, insightful, and actionable.

Endoscopic Retrograde Cholangiopancreatography Market

Base Year Value ()

CAGR ()

Forecast Year Value ()

Historical Data Period

Largest Region

Forecast Period

Instant access to hundreds of data points and trends

Marktübersicht

Frequently Asked Questions

• What is the worth of global endoscopic retrograde cholangiopancreatography market?

• What is the size of the North America endoscopic retrograde cholangiopancreatography industry?

• What are the upcoming trends of endoscopic retrograde cholangiopancreatography market, globally?

• What is the CAGR of endoscopic retrograde cholangiopancreatography market?

• Which are the top companies to hold the market share in endoscopic retrograde cholangiopancreatography market?

• What is the leading application of endoscopic retrograde cholangiopancreatography market?

• Which is the largest regional market for endoscopic retrograde cholangiopancreatography market?

Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis

Endoscopic Retrograde Cholangiopancreatography Market Players

Who Should Buy? Or Key stakeholders

Endoscopic Retrograde Cholangiopancreatography Market Regional Analysis

TABELLENLISTE

LIST OF FIGURES

DOWNLOAD FREE SAMPLE REPORT

License Type

Get Sample to Email

SPEAK WITH OUR ANALYST

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

Talk to Expert

+1 (704) 266-3234

Send an Email

Contact us

Quick Links

We accept